Status:
RECRUITING
Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer
Lead Sponsor:
Institut Claudius Regaud
Conditions:
Metastatic Breast Cancer
Metastatic Prostate Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This trial is a pilot, prospective, single-center study conducted in a population of patients with metastatic breast cancer (whatever the immunohistochemical subtype) or metastatic prostate cancer. Th...
Eligibility Criteria
Inclusion
- Patient with breast cancer (whatever the immunohistochemical subtype: triple-negative, RH+/HER2-negative or HER2-positive) or prostate cancer, multi-metastatic, eligible for a new line of treatment.
- Patient not yet initiated on a new specific treatment for breast or prostate cancer at inclusion.
- Age ≥ 18 years and WHO ≤ 2
- Patient affiliated to Social Security scheme in France.
- Patient having signed informed consent prior to inclusion in the study and prior to any study-specific procedures.
Exclusion
- Associated pathology(ies) likely to prevent the study procedure from running smoothly
- Any psychological, family, geographical or sociological condition that prevents compliance with the medical follow-up and/or procedures stipulated in the study protocol.
- Patient deprived of liberty or under legal protection (guardianship, legal protection)
- Patient who has had another solid tumor (excluding carcinoma in situ of the breast or cervix) within 5 years.
Key Trial Info
Start Date :
August 14 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06904625
Start Date
August 14 2025
End Date
May 1 2026
Last Update
August 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IUCT-O
Toulouse, France